Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure.
作者信息
Macaluso F S, Criscuoli V, Orlando E, Rizzuto G, Renna S, Cottone M, Orlando A
机构信息
Division of Internal Medicine, Di.Bi.M.I.S., "Villa Sofia-Cervello" Hospital, University of Palermo, Italy.
出版信息
Aliment Pharmacol Ther. 2016 May;43(9):1019-20. doi: 10.1111/apt.13565.
PMID:27040168
Abstract
摘要
相似文献
1
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure.信函：从一种抗肿瘤坏死因子α药物转换至另一种药物以及暴露重叠的风险。
Aliment Pharmacol Ther. 2016 May;43(9):1019-20. doi: 10.1111/apt.13565.
2
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure--authors' reply.
Aliment Pharmacol Ther. 2016 May;43(9):1020. doi: 10.1111/apt.13579.
3
Letter: tumour necrosis factor alpha blocker switching--a not so simple pharmacokinetic.
Aliment Pharmacol Ther. 2015 Jun;41(12):1302. doi: 10.1111/apt.13212.
4
Letter: tumour necrosis factor alpha blocker switching--a not so simple pharmacokinetic. Authors' reply.
Aliment Pharmacol Ther. 2015 Jun;41(12):1302-3. doi: 10.1111/apt.13222.
5
The future of inflammatory bowel disease care.炎症性肠病护理的未来。
Rev Gastroenterol Disord. 2009 Summer;9(3):E69-77.
6
Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.抗 TNF-α 药物的作用机制分子 - 治疗性 TNF-α 拮抗剂的比较。
Cytokine. 2018 Jan;101:56-63. doi: 10.1016/j.cyto.2016.08.014. Epub 2016 Aug 24.
7
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.系统评价与荟萃分析：在先前抗 TNF 治疗失败的炎症性肠病患者中使用第二种抗 TNF 的疗效。
Aliment Pharmacol Ther. 2015 Apr;41(7):613-23. doi: 10.1111/apt.13083. Epub 2015 Feb 4.
8
Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: a community practice experience.接受抗肿瘤坏死因子治疗的老年炎症性肠病患者住院率增加，但感染率未增加：一项社区实践经验。
J Crohns Colitis. 2014 Aug;8(8):898-9. doi: 10.1016/j.crohns.2013.12.016. Epub 2014 Jan 14.
9
IBD: Can TNF inhibitors be administered during the third trimester?炎症性肠病：肿瘤坏死因子抑制剂在孕晚期可以使用吗？
Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):130-1. doi: 10.1038/nrgastro.2012.248. Epub 2012 Dec 18.
10
The use of biologic agents in pregnancy and breastfeeding.生物制剂在妊娠和哺乳期的使用。
Gastroenterol Clin North Am. 2014 Sep;43(3):495-508. doi: 10.1016/j.gtc.2014.05.005. Epub 2014 Jul 5.
Zotero 插件